Transcriptomics

Dataset Information

0

Whole blood gene expression data of thrombotic and non-thrombotic critically ill COVID-19 patients


ABSTRACT: Background: COVID-19 has revealed novel pathological mechanisms, particularly hypercoagulability leading to increased thrombotic risk in critically ill patients. This study investigates transcriptional signatures associated with thrombosis development in COVID-19 intensive care unit (ICU) patients and evaluates their predictive potential. Methods: We performed whole blood transcriptional profiling of 57 mechanically ventilated COVID-19 patients, comparing those with thrombotic complications (TC, n=36) to those without (non-TC, n=21) using differential gene expression and machine learning approaches. Results: TC patients showed greater transcriptome disruption and 283 differentially expressed genes compared to non-TC patients. Key features included enhanced neutrophil activation, inflammatory responses, and monocyte activation alongside suppressed lymphocyte function. An OPLS-DA model achieved excellent classification performance (AUC=0.961, 95% CI: 0.905-0.997). The maltase-glucoamylase gene (MGAM) was the top discriminatory biomarker outperforming traditional clinical markers like D-dimer and C-reactive protein (AUC=0.94). Conclusions: Thrombotic complications in critically ill COVID-19 patients are characterized by distinct transcriptional signatures reflecting heightened neutrophil activation and inflammatory dysregulation. MGAM represents a novel potential biomarker that outperforms traditional clinical markers for identifying patients at high thrombotic risk, offering new opportunities for personalized risk stratification and management in severe COVID-19.

ORGANISM(S): Homo sapiens

PROVIDER: GSE300129 | GEO | 2025/06/18

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA1279089 | ENA
2025-04-04 | GSE293708 | GEO
2025-04-04 | GSE293707 | GEO
2021-12-08 | GSE180578 | GEO
2025-04-03 | GSE275563 | GEO
2025-04-03 | GSE249438 | GEO
| EGAS00001006266 | EGA
2023-02-23 | PXD037898 | Pride
2021-04-30 | E-MTAB-10431 | biostudies-arrayexpress
2024-05-22 | GSE233626 | GEO